Case study
Perfectus Biomed Group
Perfectus Biomed Group (PBG) is a leading international Contract Research Organisation (CRO) that provides microbiological and biological testing services to the Medtech and Biopharma industries.
Proving that campus companies at Liverpool City Region’s Sci-Tech Daresbury are adept at adjusting when required, PBG responded to the coronavirus pandemic by focusing its resources and knowledge on their Virology expertise and service offerings in order to cater for the growing demand for testing of biocidal products including disinfectants and hand sanitising gels, while also reducing the cost of its testing service to make it quicker for more high-standard (or, urgently needed) products to get to market.
Our mission as a business is to improve quality of life by providing exceptional scientific services across a wide spectrum of healthcare industries. during the early stages of the pandemic, we saw that as more important than ever. Whether this involved adapting our services to support the development of biocidal products or supporting our Sci-Tech Daresbury neighbours in helping to get their products into hospitals, we were committed to using our diverse scientific expertise to support the global fight against coronavirus.
The work we achieved over the past few years would not have been possible without our teams’ versatility, willingness, and enthusiasm. Whether that was maintaining social distancing in a lab environment on site at Sci-Tech Daresbury or delivering vital business and admin support while working from home. It’s been inspiring to see how such important work can be achieved in difficult and disruptive circumstances.
– Dr Samantha Westgate, Chief Executive at Perfectus Biomed
A successful merger
PBG successfully completed a merger with a US based CRO and expanded its laboratory facilities at Sci-Tech Daresbury in the midst of the pandemic, reflecting the ‘home for life’ ethos that sees existing campus companies scale up on site to larger offices and laboratories in order to meet their growth ambitions.
It seems remarkable that two of our companies had gone to market with their collaboration at the start of April, which in hindsight was the early stages of the pandemic, yet it perfectly illustrates how our companies are dexterous, resilient and so often have the foresight to develop products and services before the wider world appreciates just how important they will be.
